Cipro Purchasers Tell Calif. High Court That Reverse Payments Violate State Law

SAN FRANCISCO - Purchasers of Cipro on March 27 filed their opening brief urging the California Supreme Court to review the Court of Appeal's ruling that pay-for-delay settlement agreements between the manufacturer of a branded antibiotic and its generic competitors do not violate California antitrust laws (In re Cipro Cases I & II, No. S198616, Calif. Sup.). See related, In re Cipro Cases I & II.

Find full version on lexis Advance®